Irritable bowel syndrome symptom severity improves equally with probiotic and placebo

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 48

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Dec 28, 2016; 22(48): 10631-10642
Published online Dec 28, 2016. doi: 10.3748/wjg.v22.i48.10631

Table 2 Irritable bowel syndrome symptom characteristics n (%)

	Placebo (n = 131)	Low-dose (n = 129)	High-dose (n = 131)
IBS subtype
IBS-C	25 (19.1)	20 (15.5)	20 (15.3)
IBS-D	49 (37.4)	51 (39.5)	52 (39.7)
IBS-M	56 (42.7)	58 (45.0)	58 (44.3)
IBS-U	1 (0.8)	0 (0.0)	1 (0.8)
Postinfectious IBS	9 (6.9)	4 (3.1)	7 (5.3)
Psychological comorbidities	9 (6.9)	6 (4.7)	13 (9.9)
Symptoms provoked by specific food	103 (79.8)¹	116 (89.9)	120 (91.6)
Family history of intestinal disorders or diseases	95 (72.5)	97 (75.2)	92 (70.8)²

¹Two volunteers not analysed;

²One volunteer not analyzed. IBS: Irritable bowel syndrome.

Citation: Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. World J Gastroenterol 2016; 22(48): 10631-10642
URL: https://www.wjgnet.com/1007-9327/full/v22/i48/10631.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i48.10631

Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. World J Gastroenterol 2016; 22(48): 10631-10642 [PMID: 28082816 DOI: 10.3748/wjg.v22.i48.10631]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.